Penny Durham

For at least one of these immune-mediated skin conditions, weight loss reduced the risk. 

The FDA is up to more of its malarkey with the latest amyloid-targeting drug, a BMJ investigation finds.

Living longer is something to celebrate, but chronic disease comes quicker. A free package of treatment algorithms is available for GPs.

A large systematic review has also found increased risk of ADHD and other problems that weight management may mitigate.

Pulmonary rehab is an effective but underutilised way to improve quality of life for the many people living with this disease.

A new study uses naloxone to explore why men get more relief from opioids – exo- and endogenous – than women.

Hearing aids do not appear to slow the cognitive decline associated with hearing loss.

Older people continue to bear the brunt of mortality.

Although GLP-1 receptor agonists and SGLT2 inhibitors can improve quality of life, it's dangerous territory for GPs.

Dapagliflozin is now more broadly subsidised following a price change. Also, two insulin delivery devices have important defects.